Tag: Centers

News (12)

March 21, 2017 9:00 am

Federal advisory panels agree Opana's risks outweigh benefits (USA Today)

The new extended-release version of Endo Pharmaceuticals’ Opana may even be more dangerous than the version it replaced, according to critics including the advocacy group Public Citizen. Two Food and Drug Administration advisory panels seemed to agree, voting 18 to 8 that it presents more risks than benefits to society. Next it’s up to the FDA to decide whether to act on the panels’ advice, which it generally does. Possible actions include changes to labels, restriction of prescriptions and an outright ban.

February 27, 2017 9:00 am

U.S. researchers guilty of misconduct later won more than $100 million in NIH grants, study finds (Science)

Overall, 23 of the scientists (roughly 8% of sanctioned researchers) received NIH funding after receiving an ORI sanction. Of that group, 17 researchers won more than $101 million for 61 new projects. Thirteen continued to receive funding from NIH grants that had been awarded before being sanctioned.

February 16, 2017 9:00 am

Speedy drug approvals are risky, but drug companies have another idea that's just terrible (Los Angeles Times)

As with Trump’s proposed elimination of consumer safeguards, environmental-protection measures and financial reforms, the reality is that if his administration proceeds with a wholesale deregulation of the drug industry, the public will be largely undefended against the aggressive and potentially dangerous predations of multibillion-dollar conglomerates.

February 14, 2017 9:00 am

French auditors criticize €5-billion science super-campus near Paris (Nature)

France’s government auditor has taken a sharp swipe at efforts to develop a science super-campus near Paris that, by 2020, was supposed to rival the world’s top campus universities, such as the US Massachusetts Institute of Technology (MIT). More than €5.3 billion (US$5.7 billion) in public spending has been earmarked for the Paris-Saclay science cluster, the Court of Auditors estimates in an annual report published on 8 February — but the original vision of creating a large integrated research university there is “at a standstill”.

February 13, 2017 9:00 am

Senate confirms Price to lead HHS (Science)

Price now takes the helm of a $1 trillion government department that includes the National Institutes of Health (NIH), the Centers for Disease Control and Prevention, and the Food and Drug Administration (FDA). Most visibly, he will be charged with overseeing the repeal and replacement of the Affordable Care Act, also known as Obamacare, that Republicans have promised.

February 9, 2017 9:00 am

India scraps funding ties with Gates Foundation on immunization (Reuters)

A group backed by the Bill & Melinda Gates Foundation that works on India’s immunization program will now be funded by the health ministry, a government official said, a move in part prompted by fears foreign donors could influence policy making.

February 6, 2017 9:00 am

Will the Trump presidency mean the end of FDA drug regulation? (Los Angeles Times)

Donald Trump will be coming into office waving the banner of deregulation. While most of the speculation about his plans has focused on the financial industry and the possibility of eviscerating Dodd-Frank reforms, keep your eyes on the Food and Drug Administration. In a Trump administration the agency, figuratively speaking, will have a big bull’s-eye on its back.

January 25, 2017 9:00 am

We spoke with the man who could lead the world's top health organization (Business Insider)

The WHO lost a lot of trust in the aftermath of the 2014 Ebola outbreak in West Africa. Nabarro said his hope is to make sure that doesn’t happen again.

January 23, 2017 9:00 am

Trump asks NIH Director Francis Collins to stay on (Science)

Ending weeks of speculation, President-elect Donald Trump has asked National Institutes of Health (NIH) Director Francis Collins to remain in his position. It is not clear for how long.

January 9, 2017 9:00 am

Fact-checking Congress’s fetal tissue report (Science)

They interviewed senior physicians from Planned Parenthood, who spoke bluntly about their provision of fetal tissue from legal abortions for medical research

View More News Items